Top Tech Companies (2,068)
Don't see your company?
Create a company profile
Our clinical trial solutions empower biopharma, medical device and CRO organizations to accelerate development. Contact us for trial management services.
BioAtla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. The culmination of our discovery and evolution expertise and more than 150 issued patents and patent applications is our Conditionally Active Biologics (CAB) platform, whereby monoclonal antibodies or other biologics can be engineered for selective conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. This improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. BioAtla is applying these technologies in our own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.
Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company
Science first biotech accelerator and IP commercialization
Aromyx has introduced unbiased, quantitative measurement of how humans perceive taste and smell. We have merged biotechnology, data science, and AI to replicate the power of flavors and aromas. Our technology allows companies to optimize flavors and scents that drive product development, consumer preferences, and purchase behavior.
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Ambry Genetics is a company built by scientists, genetic counselors and physicians, dedicated to leading the clinical genomic diagnostic industry. Ambry boasts the largest genetic sequencing lab in the world; is CAP-accredited, CLIA-licensed and, as part of the Konica Minolta family, has access to the most complete suite of diagnostic technology in the world. Ambry Genetics' scope of clients includes some of the world's most respected academic institutions, pharmaceutical companies and leading treatment hospitals. Our experience, technology and dedication to science make us a trusted source for all clinical genetic testing, and an ideal partner for developing precision medicine solutions. Patients are at the core of everything we do, which is why Ambry partners with several non-profit organizations so that we can help both patients and clinicians alike find answers.
Exporting antibodies from human cells to humanity.
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. Tandem takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. The t:slim X2 pump is capable of remote feature updates using a personal computer. Tandem is based in San Diego, California.
Blue Water Vaccines is a company developing a universal flu vaccine based on technology.
Exagen Inc. is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, our AVISE tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information on our company, please visit www.Exagen.com. For more information on AVISE testing services, please visit www.AviseTest.com. Read our Social Media Terms of Use here: http://bit.ly/smtou
A personalized medicine company and clinical laboratory focused on autoimmune neuropsychiatric disorders in children and adults.
Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.
Tangen Biosciences, Inc. was founded in 2013 and is located in Branford, Connecticut. The company developed the TangenDx™ platform for fast and accurate detection of targeted DNAs and RNAs directly from specimens by using rotary rapid isothermal nucleic acid detection. The Tangen system consists of the TangenDx™ disc and the GeneSpark™ instrument, an automated amplification device. The TangenDx™ platform, which does not require laboratory facilities, is expected to deliver faster, simpler, more sensitive detection at a lower cost than other commercial technologies. Current tests in development include COVID-19, Candida auris, sepsis causing bacterial panel, antibiotic resistance genes, and a fungal blood panel. The system can process samples from whole blood, sputum, skin swabs, nasopharyngeal swabs, etc. The TangenDx FluA/B, RSV, and SARS-CoV-2 Panel assay planned to be released by the upcoming fall season.
Thermalin offers insulins and delivery systems that transform the economic, treatment, and disease management paradigms for diabetes.
Biora Therapeutics is reimagining therapeutics by creating smart pills designed for - targeted drug delivery to the GI tract, and - systemic, needle-free delivery of biotherapeutics we are developing therapies to improve patients’ lives. At Biora, we envision a world where patients have access to needle-free drug delivery and better therapeutic outcomes. We welcome you to learn more about our mission and our guiding principles at https://bioratherapeutics.com/company/about
Immunetrics takes a Quantitative Systems Pharmacology (QSP) approach to creating mechanistic mathematical models of biological systems, accelerating development of drugs, clinical diagnostics, and medical/commercial devices. We predict FDA-approved endpoints through in silico clinical trial simulations of acute or chronic inflammatory diseases. We deliver proprietary mathematical models encompassing biological pathways and interactions that span levels of detail from intracellular signaling pathways, cell-cell interactions, and organ systems. We also utilize complex analyses to help better understand your data and create novel hypotheses. Our robust bio-simulation platform represents 10+ years of work by our team of experts. Our capabilities allow our clients to bring their health care solutions to market more quickly, at a lower cost, and with decreased risk. Immunetrics was founded in 2001 and collaborates regularly with the most significant names in drug development, medical devices, and academia. Our team includes a cross disciplinary group of experts in physiology, molecular biology, immunology, computational biology, machine learning, and software engineering in a highly collaborative environment. We provide the expertise and experience to build functional models to inform our clients in their decision making process. Immunetrics' offices and computing center are conveniently located in South Side of Pittsburgh, PA. Our city is the home of the University of Pittsburgh Medical Center, with its world-class Critical Care Medicine, Surgery and Immunology departments; Carnegie Mellon University, with its world-renowned Engineering and Mathematics groups; and the Pittsburgh Supercomputing Center.
NovoPedics is a biotechnology company developing implantable meniscus replacement and regeneration medical devices.
As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by Planova™ virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, Planova™ filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers with products, services and expertise to achieve assurance that is beyond expectation. As part of our dedication to solving therapeutic product safety, efficiency and purity challenges, we also manufacture a comprehensive suite of downstream equipment. With technology platforms for virus filtration, chromatography, inline buffer formulation and oligonucleotide synthesis, our bioprocessing systems, columns and automation solutions advance GMP manufacturing of critical drug substances around the world. Our portfolio of market-driven equipment and cutting-edge technology touches unit operations across a wide range of therapeutic modalities, including classical small molecule pharmaceuticals, current-generation antibodies, plasma derivatives and next-generation oligonucleotide therapeutics.
